OZEM
Roundhill GLP-1 & Weight Loss ETF·NASDAQ
--
--(--)
--
--(--)
Key Stats
Assets Under Management
58.08MUSD
Fund Flows (1Y)
5.33MUSD
Dividend Yield
1.17%
Discount/Premium to NAV
-0.30%
Shares Outstanding
1.67M
Expense Ratio
0.59%
About Roundhill GLP-1 & Weight Loss ETF
Issuer
--
Brand
--
Home Page
--
Inception Date
--
Structure
--
Index Tracked
--
Management Style
--
Dividend Treatment
--
Distribution Tax Treatment
--
Income Tax Type
--
Max ST Capital Gains Rate
--
Max LT Capital Gains Rate
--
Primary Advisor
--
Distributor
--
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Pharma, Biotech & Life Sciences
Strategy
Active
Geography
--
Weighting Scheme
Proprietary
Selection Criteria
Proprietary
Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Holdings
Symbol
Ratio
NVO
Novo Nordisk
17.10%
LLY
Eli Lilly
15.50%
Roche Holding AG
4.75%
Chugai Pharmaceutical Co Ltd
4.46%
GPCR
Structure
4.36%
PFE
Pfizer
4.33%
Symbol
Ratio
Ascletis Pharma Inc
4.15%
Hanmi Pharm Co Ltd
4.10%
AMGN
Amgen
4.09%
Zealand Pharma A/S
3.98%
Top 10 Weight 66.82%
10 Total Holdings
See all holdings
Related Funds
EPIN
Harbor International Equity ETF0
+0.00%
DFUV
Dimensional US Marketwide Value ETF0
+0.00%
CGMM
Capital Group U.S. Small and Mid Cap ETF0
+0.00%
FAPR
FT Vest U.S. Equity Buffer ETF - April0
+0.00%
GPT
Intelligent Alpha Atlas ETF0
+0.00%
FOCT
FT Vest U.S. Equity Buffer ETF - October0
+0.00%
GAUD
Guinness Atkinson US Dividend Builder ETF0
+0.00%
HRTS
Tema Heart & Health ETF0
+0.00%
Seasonals
Volume Profile
Trade Flow Insight
Community Forum
Loading...
Related News
No articles available
You can ask Aime
No Data
